Downstream of this event, inhibition of E2F1 was found to reduce the proliferation of CML SPCs and induce p53-mediated apoptosis, but healthy SPCs were not affected by inhibition of the E2F1 pathway (21). The gene discussed is E2F1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.